A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Learn about women in STEM and the vital role of Dr Lidia Serina in advancing biopharma therapies and empowering women.

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

In part due to research by two University of Michigan researchers, a form of leukemia can be treated more easily through an FDA-approved drug.

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...